Skip to content

Solventum

US · SOLV #1124 by market cap Listed 2024
84.50 -1.30 -1.52%
Periodic snapshot; not a real-time feed. · 2026-11-20 20:02

✦ Quant Ownership Signal how this is computed

Accumulating
  • The number of reporting institutions decreased by 2 in the most recent period (2026/Q4).
  • Total institutional ownership rose 0.1 percentage points.

Ownership vs. money flow

Diverging

Institutions added shares last reporting period, and the stock has seen net outflows in main-fund flow over the last 20 trading sessions - the two are pointing in different directions.

Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.

Institutional ownership

Held by institutions
93.56% +0.12pp
Institutions
1,051 -2
As of
2026/Q4 vs. prior period

Holder types

Mutual Fund59.63%
Public Company17.70%
Hedge Fund11.23%
Private Company2.17%
Government Pension Fund1.15%
Sovereign Wealth Fund1.01%
Family Office/Trust0.27%
Individual/Insider0.26%
Insurance Company0.25%
Other6.32%

Top holders as of 2026-03-19

3M Company 15.06% · 25.57M sh
Independent Franchise Partners, LLP 9.23% · 15.67M sh
Vanguard Capital Management, LLC 6.06% · 10.29M sh
BlackRock 5.63% · 9.56M sh
Trian Fund Management, L.P. 4.85% · 8.24M sh
Davis Selected Advisers LP 3.78% · 6.41M sh
Vanguard Portfolio Management, LLC 3.65% · 6.20M sh
State Street Global Advisors 3.31% · 5.61M sh
Geode Capital Management, LLC 2.92% · 4.96M sh
Boston Partners Global Investors, Inc. 2.11% · 3.58M sh

Bar length is relative to the largest holder shown here, not to 100% of the company.

Insiders

50 filings tracked · 42 buys · 8 sells

NameRoleStake
3M Company -- 15.06%
Bryan Hanson Chief Executive Officer 0.11%
Wayde McMillan Chief Financial Officer 0.03%
Amy Landucci Chief Information & Digital Officer 0.02%
Paul Harrington Former Chief Supply Chain Officer 0.01%
Carrie Cox Independent Chairperson 0.01%
Marcela Kirberger Chief Corporate & Legal Affairs Officer & Corporate Secretary 0.01%
Tammy Gomez Chief Human Resources Officer 0.01%
Amy McBride-Wendell Independent Director 0.01%
James Barry Former Executive VP & Group President of Medical Surgical 0.01%

Insider transactions most recent Form 4 filings

DateNameRoleTypeSharesPrice
2026-08-31 Bryan Hanson Chief Executive Officer Derivative Exercise and Sale -26,468 $90.95
2026-08-31 Bryan Hanson Chief Executive Officer Derivative Exercise and Retained +40,793 --
2026-08-16 Neil Zieselman Chief Accounting Officer Other Derivative Acquisition +6,911 --
2026-05-14 Carrie Cox Independent Chairperson Other Derivative Acquisition +4,848 --
2026-05-14 John Weiland Independent Director Other Derivative Acquisition +3,300 --
2026-05-14 Karen May Independent Director Other Derivative Acquisition +3,300 --
2026-05-14 Amy McBride-Wendell Independent Director Other Derivative Acquisition +3,300 --
2026-05-14 Glenn Eisenberg Independent Director Other Derivative Acquisition +3,300 --
2026-05-14 Bernard Harris Independent Director Other Derivative Acquisition +3,300 --
2026-05-14 Susan DeVore Independent Director Other Derivative Acquisition +3,300 --
2026-05-14 Carlos Alban Independent Director Other Derivative Acquisition +3,300 --
2026-05-14 Darryl Wilson Independent Director Other Derivative Acquisition +3,300 --
2026-05-14 Elizabeth Mily Independent Director Other Derivative Acquisition +3,300 --
2026-05-14 Shirley Edwards Independent Director Other Derivative Acquisition +3,300 --
2026-05-12 Wayde McMillan Chief Financial Officer Derivative Exercise and Sale -4,404 $74.41
2026-05-12 Wayde McMillan Chief Financial Officer Derivative Exercise and Retained +5,099 --
2026-05-12 Bryan Hanson Chief Executive Officer Derivative Exercise and Sale -13,503 $74.41
2026-05-12 Bryan Hanson Chief Executive Officer Derivative Exercise and Retained +20,812 --
2026-05-12 Marcela Kirberger Chief Corporate & Legal Affairs Officer & Corporate Secretary Derivative Exercise and Sale -1,952 $74.41
2026-05-12 Marcela Kirberger Chief Corporate & Legal Affairs Officer & Corporate Secretary Derivative Exercise and Retained +2,536 --

Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.

Quote time 2026-11-20 20:02:28 · For reference only, not investment advice and not tailored to your situation.

Solventum discussion 0 comments

Add a comment